1.

Huttlin

EL

,

Bruckner

RJ

,

Paulo

JA

,

Cannon

JR

,

Ting

L

,

Baltier

K

, .

Architecture of the human interactome defines protein communities and disease networks

.

Nature

.

2017

;

545

(

7655

):

505

–

9

.

2.

Turck

CW

,

Webhofer

C

,

Nussbaumer

M

,

Teplytska

L

,

Chen

A

,

Maccarrone

G

, .

Stable isotope metabolic labeling suggests differential turnover of the DPYSL protein family

.

Proteomics Clin Appl

.

2016

;

10

(

12

):

1269

–

72

.

3.

Ricard

D

,

Rogemond

V

,

Charrier

E

,

Aguera

M

,

Bagnard

D

,

Belin

MF

, .

Isolation and expression pattern of human Unc-33-like phosphoprotein 6/collapsin response mediator protein 5 (Ulip6/CRMP5): coexistence with Ulip2/CRMP2 in Sema3a- sensitive oligodendrocytes

.

J Neurosci

.

2001

;

21

(

18

):

7203

–

14

.

4.

Charrier

E

,

Reibel

S

,

Rogemond

V

,

Aguera

M

,

Thomasset

N

,

Honnorat

J

.

Collapsin response mediator proteins (CRMPs): involvement in nervous system development and adult neurodegenerative disorders

.

Mol Neurobiol

.

2003

;

28

(

1

):

51

–

64

.

5.

Auvergnon

N

,

Reibel

S

,

Touret

M

,

Honnorat

J

,

Baron

T

,

Giraudon

P

, .

Altered expression of CRMPs in the brain of bovine spongiform encephalopathy-infected mice during disease progression

.

Brain Res

.

2009

;

1261

:

1

–

6

.

6.

Bretin

S

,

Reibel

S

,

Charrier

E

,

Maus-Moatti

M

,

Auvergnon

N

,

Thevenoux

A

, .

Differential expression of CRMP1, CRMP2A, CRMP2B, and CRMP5 in axons or dendrites of distinct neurons in the mouse brain

.

J Comp Neurol

.

2005

;

486

(

1

):

1

–

17

.

7.

Fukata

Y

,

Itoh

TJ

,

Kimura

T

,

Ménager

C

,

Nishimura

T

,

Shiromizu

T

, .

CRMP-2 binds to tubulin heterodimers to promote microtubule assembly

.

Nat Cell Biol

.

2002

;

4

(

8

):

583

–

91

.

8.

Yuasa-Kawada

J

,

Suzuki

R

,

Kano

F

,

Ohkawara

T

,

Murata

M

,

Noda

M

.

Axonal morphogenesis controlled by antagonistic roles of two CRMP subtypes in microtubule organization

.

Eur J Neurosci

.

2003

;

17

(

11

):

2329

–

43

.

9.

Quach

TT

,

Duchemin

AM

,

Rogemond

V

,

Aguera

M

,

Honnorat

J

,

Belin

MF

, .

Involvement of collapsin response mediator proteins in the neurite extension induced by neurotrophins in dorsal root ganglion neurons

.

Mol Cell Neurosci

.

2004

;

25

(

3

):

433

–

43

.

10.

Kurnellas

MP

,

Li

H

,

Jain

MR

,

Giraud

SN

,

Nicot

AB

,

Ratnayake

A

, .

Reduced expression of plasma membrane calcium ATPase 2 and collapsin response mediator protein 1 promotes death of spinal cord neurons

.

Cell Death Differ

.

2010

;

17

(

9

):

1501

–

10

.

11.

Minturn

JE

,

Fryer

HJ

,

Geschwind

DH

,

Hockfield

S

.

TOAD-64, a gene expressed early in neuronal differentiation in the rat, is related to unc-33, a C. elegans gene involved in axon outgrowth

.

J Neurosci

.

1995

;

15

(

10

):

6757

–

66

.

12.

Goshima

Y

,

Nakamura

F

,

Strittmatter

P

,

Strittmatter

SM

.

Collapsin-induced growth cone collapse mediated by an intracellular protein related to UNC-33

.

Nature

.

1995

;

376

(

6540

):

509

–

14

.

13.

Zhang

JN

,

Koch

JC

.

Collapsin response mediator protein-2 plays a major protective role in acute axonal degeneration

.

Neural Regen Res

.

2017

;

12

(

5

):

692

–

5

.

14.

Byk

T

,

Dobransky

T

,

Cifuentes-Diaz

C

,

Sobel

A

.

Identification and molecular characterization of Unc-33-like phosphoprotein (Ulip), a putative mammalian homolog of the axonal guidance-associated unc-33 gene product

.

J Neurosci

.

1996

;

16

(

2

):

688

–

701

.

15.

Fukada

M

,

Watakabe

I

,

Yuasa-Kawada

J

,

Kawachi

H

,

Kuroiwa

A

,

Matsuda

Y

, .

Molecular characterization of CRMP5, a novel member of the collapsin response mediator protein family

.

J Biol Chem

.

2000

;

275

(

48

):

37957

–

65

.

16.

Deo

RC

,

Schmidt

EF

,

Elhabazi

A

,

Togashi

H

,

Burley

SK

,

Strittmatter

SM

.

Structural bases for CRMP function in plexin-dependent semaphorin3A signaling

.

Embo J

.

2004

;

23

(

1

):

9

–

22

.

18.

Petratos

S

,

Lee

JY

.

Stop CRMPing my style: a new competitive model of CRMP oligomerization

.

J Neurochem

.

2013

;

125

(

6

):

800

–

2

.

19.

Inatome

R

,

Tsujimura

T

,

Hitomi

T

,

Mitsui

N

,

Hermann

P

,

Kuroda

S

, .

Identification of CRAM, a novel unc-33 gene family protein that associates with CRMP3 and protein-tyrosine kinase(s) in the developing rat brain

.

J Biol Chem

.

2000

;

275

(

35

):

27291

–

302

.

20.

Wang

LH

,

Strittmatter

SM

.

A family of rat CRMP genes is differentially expressed in the nervous system

.

J Neurosci

.

1996

;

16

(

19

):

6197

–

207

.

21.

Hou

ST

.

The regulatory and enzymatic functions of CRMPs in neuritogenesis, synaptic plasticity, and gene transcription

.

Neurochem Int

.

2020

;

139

:

104795

.

22.

Guo

GQ

,

Zhang

JF

,

Xin

L

,

Chen

J

,

Shen

WZ

,

Yuan

L

, .

mRNA expression of Rho GTPase-related signaling molecules during rat hippocampal development

.

Neural Regen Res

.

2009

;

4

(

10

):

786

–

90

.

23.

Lin

YS

,

Lin

YF

,

Chen

KC

,

Yang

YK

,

Hsiao

YH

.

Collapsin response mediator protein 5 (CRMP5) causes social deficits and accelerates memory loss in an animal model of Alzheimer’s disease

.

Neuropharmacology

.

2019

;

157

:

107673

.

24.

Moutal

A

,

White

KA

,

Chefdeville

A

,

Laufmann

RN

,

Vitiello

PF

,

Feinstein

D

, .

Dysregulation of CRMP2 post-translational modifications drive its pathological functions

.

Mol Neurobiol

.

2019

;

56

(

10

):

6736

–

55

.

25.

Tsutiya

A

,

Ohtani-Kaneko

R

.

Postnatal alteration of collapsin response mediator protein 4 mRNA expression in the mouse brain

.

J Anat

.

2012

;

221

(

4

):

341

–

51

.

26.

Dubey

D

,

Lennon

VA

,

Gadoth

A

,

Pittock

SJ

,

Flanagan

EP

,

Schmeling

JE

, .

Autoimmune CRMP5 neuropathy phenotype and outcome defined from 105 cases

.

Neurology

.

2018

;

90

(

2

):

e103

–

e10

.

27.

Lauzi

J

,

Anders

F

,

Liu

H

,

Pfeiffer

N

,

Grus

F

,

Thanos

S

, .

Neuroprotective and neuroregenerative effects of CRMP-5 on retinal ganglion cells in an experimental in vivo and in vitro model of glaucoma

.

PLoS One

.

2019

;

14

(

1

):

e0207190

.

28.

Albright

TD

,

Jessell

TM

,

Kandel

ER

,

Posner

MI

.

Neural science: a century of progress and the mysteries that remain

.

Cell

.

2000

;

100

:

S1

–

55

.

29.

Terenzio

M

,

Schiavo

G

,

Fainzilber

M

.

Compartmentalized signaling in neurons: from Cell biology to neuroscience

.

Neuron

.

2017

;

96

(

3

):

667

–

79

.

30.

O'Toole

M

,

Lamoureux

P

,

Miller

KE

.

Measurement of subcellular force generation in neurons

.

Biophys J

.

2015

;

108

(

5

):

1027

–

37

.

31.

Li

JN

,

Jiang

JD

.

Biological characteristics of microtubule and related drug research

.

Yao Xue Xue Bao

.

2003

;

38

(

4

):

311

–

5

.

32.

Zhou

FQ

,

Snider

WD

.

Intracellular control of developmental and regenerative axon growth

.

Philos Trans R Soc Lond B Biol Sci

.

2006

;

361

(

1473

):

1575

–

92

.

33.

Li

W

,

Herman

RK

,

Shaw

JE

.

Analysis of the caenorhabditis elegans axonal guidance and outgrowth gene unc-33

.

Genetics

.

1992

;

132

(

3

):

675

–

89

.

34.

Uchida

Y

,

Ohshima

T

,

Yamashita

N

,

Ogawara

M

,

Sasaki

Y

,

Nakamura

F

, .

Semaphorin3A signaling mediated by fyn-dependent tyrosine phosphorylation of collapsin response mediator protein 2 at tyrosine 32

.

J Biol Chem

.

2009

;

284

(

40

):

27393

–

401

.

35.

Yamashita

N

,

Morita

A

,

Uchida

Y

,

Nakamura

F

,

Usui

H

,

Ohshima

T

, .

Regulation of spine development by semaphorin3A through cyclin-dependent kinase 5 phosphorylation of collapsin response mediator protein 1

.

J Neurosci

.

2007

;

27

(

46

):

12546

–

54

.

36.

Quach

TT

,

Massicotte

G

,

Belin

MF

,

Honnorat

J

,

Glasper

ER

,

Devries

AC

, .

CRMP3 is required for hippocampal CA1 dendritic organization and plasticity

.

Faseb J

.

2008

;

22

(

2

):

401

–

9

.

37.

Ohtani-Kaneko

R

.

Crmp4-KO mice as an animal model for investigating certain phenotypes of autism spectrum disorders

.

Int J Mol Sci

.

2019

;

20

(

10

):

2485

.

38.

Naudet

N

,

Moutal

A

,

Vu

HN

,

Chounlamountri

N

,

Watrin

C

,

Cavagna

S

, .

Transcriptional regulation of CRMP5 controls neurite outgrowth through Sox5

.

Cell Mol Life Sci

.

2018

;

75

(

1

):

67

–

79

.

39.

Kalpachidou

T

,

Spiecker

L

,

Kress

M

,

Quarta

S

.

Rho GTPases in the physiology and pathophysiology of peripheral sensory neurons

.

Cells

.

2019

;

8

(

6

):

591

.

40.

Arimura

N

,

Menager

C

,

Fukata

Y

,

Kaibuchi

K

.

Role of CRMP-2 in neuronal polarity

.

J Neurobiol

.

2004

;

58

(

1

):

34

–

47

.

41.

Yamashita

N

.

Retrograde signaling via axonal transport through signaling endosomes

.

J Pharmacol Sci

.

2019

;

141

(

2

):

91

–

6

.

42.

Kawashima

T

,

Jitsuki-Takahashi

A

,

Takizawa

K

,

Jitsuki

S

,

Takahashi

T

,

Ohshima

T

, .

Phosphorylation of collapsin response mediator protein 1 (CRMP1) at tyrosine 504 residue regulates semaphorin 3A-induced cortical dendritic growth

.

J Neurochem

.

2021

;

157

(

4

):

1207

–

21

.

43.

Jiang

T

,

Zhang

GW

,

Liang

YZ

,

Cai

ZB

,

Liang

Z

,

Lin

HS

, .

PlexinA3 interacts with CRMP2 to mediate sema3A signalling during dendritic growth in cultured cerebellar granule neurons

.

Neuroscience

.

2020

;

434

:

83

–

92

.

44.

Rippin

I

,

Eldar-Finkelman

H

.

Mechanisms and therapeutic implications of GSK-3 in treating neurodegeneration

.

Cells

.

2021

;

10

(

2

):

262

.

45.

Lin

XH

,

Chen

HB

,

Chen

ML

,

Li

T

,

Lai

YX

,

Lin

LZ

, .

Bone marrow-derived mesenchymal stem cells improve post-ischemia neurological function in rats via the PI3K/AKT/GSK-3β/CRMP-2 pathway

.

Mol Cell Biochem

.

2021

;

476

(

5

):

2193

–

201

.

46.

Fan

LY

,

Mao

CY

,

Hu

XC

,

Zhang

S

,

Yang

ZH

,

Hu

ZW

, .

New insights into the pathogenesis of alzheimer’s disease

.

Front Neurol

.

2019

;

10

:

1312

.

47.

Harari

O

,

Cruchaga

C

,

Kauwe

JS

,

Ainscough

BJ

,

Bales

K

,

Pickering

EH

, .

Phosphorylated tau-Aβ42 ratio as a continuous trait for biomarker discovery for early-stage Alzheimer’s disease in multiplex immunoassay panels of cerebrospinal fluid

.

Biol Psychiatry

.

2014

;

75

(

9

):

723

–

31

.

48.

Lawal

MF

,

Olotu

FA

,

Agoni

C

,

Soliman

ME

.

Exploring the C-terminal tail dynamics: structural and molecular perspectives into the therapeutic activities of novel CRMP-2 inhibitors, naringenin and naringenin-7-O-glucuronide, in the treatment of Alzheimer’s disease

.

Chem Biodivers

.

2018

;

15

(

12

):

e1800437

.

49.

Mokhtar

SH

,

Kim

MJ

,

Magee

KA

,

Aui

PM

,

Thomas

S

,

Bakhuraysah

MM

, .

Amyloid-beta-dependent phosphorylation of collapsin response mediator protein-2 dissociates kinesin in Alzheimer’s disease

.

Neural Regen Res

.

2018

;

13

(

6

):

1066

–

80

.

50.

Nakamura

H

,

Takahashi-Jitsuki

A

,

Makihara

H

,

Asano

T

,

Kimura

Y

,

Nakabayashi

J

, .

Proteome and behavioral alterations in phosphorylation-deficient mutant collapsin response mediator protein2 knock-in mice

.

Neurochem Int

.

2018

;

119

:

207

–

17

.

51.

Sveinbjornsdottir

S

.

The clinical symptoms of Parkinson’s disease

.

J Neurochem

.

2016

;

139

(

Suppl 1

):

318

–

24

.

52.

Li

W

,

Goshima

Y

,

Ohshima

T

.

Loss of collapsin response mediator protein 4 attenuates 6-hydroxydopamine-induced impairments in a mouse model of Parkinson’s disease

.

Neurochem Res

.

2020

;

45

(

10

):

2286

–

301

.

53.

Fang

W

,

Gao

GD

,

Zhao

H

,

Xia

Y

,

Guo

X

,

Li

N

, .

Role of the Akt/GSK-3β/CRMP-2 pathway in axon degeneration of dopaminergic neurons resulting from MPP+ toxicity

.

Brain Res

.

2015

;

1602

:

9

–

19

.

55.

Numata-Uematsu

Y

,

Wakatsuki

S

,

Nagano

S

,

Shibata

M

,

Sakai

K

,

Ichinohe

N

, .

Inhibition of collapsin response mediator protein-2 phosphorylation ameliorates motor phenotype of ALS model mice expressing SOD1G93A

.

Neurosci Res

.

2019

;

139

:

63

–

8

.

56.

Maimon

R

,

Ankol

L

,

Gradus Pery

T

,

Altman

T

,

Ionescu

A

,

Weissova

R

, .

A CRMP4-dependent retrograde axon-to-soma death signal in amyotrophic lateral sclerosis

.

Embo J

.

2021

;

40

(

17

):

e107586

.

57.

Klockgether

T

,

Mariotti

C

,

Paulson

HL

.

Spinocerebellar ataxia

.

Nat Rev Dis Primers

.

2019

;

5

(

1

):

24

.

58.

Winkler

SC

,

Shimobayashi

E

,

Kapfhammer

JP

.

PKCγ-mediated phosphorylation of CRMP2 regulates dendritic outgrowth in cerebellar purkinje cells

.

Mol Neurobiol

.

2020

;

57

(

12

):

5150

–

66

.

59.

Elshahabi

A

,

Klamer

S

,

Sahib

AK

,

Lerche

H

,

Braun

C

,

Focke

NK

.

Magnetoencephalography reveals a widespread increase in network connectivity in idiopathic/genetic generalized epilepsy

.

PLoS One

.

2015

;

10

(

9

):

e0138119

.

60.

Wilson

SM

,

Moutal

A

,

Melemedjian

OK

,

Wang

Y

,

Ju

W

,

François-Moutal

L

, .

The functionalized amino acid (S)-Lacosamide subverts CRMP2-mediated tubulin polymerization to prevent constitutive and activity-dependent increase in neurite outgrowth

.

Front Cell Neurosci

.

2014

;

8

:

196

.

61.

Nirwan

N

,

Siraj

F

,

Vohora

D

.

Inverted-U response of lacosamide on pilocarpine-induced status epilepticus and oxidative stress in C57BL/6 mice is independent of hippocampal collapsin response mediator protein-2

.

Epilepsy Res

.

2018

;

145

:

93

–

101

.

62.

Qin

L

,

Liu

X

,

Liu

SY

,

Liu

Y

,

Yang

YX

,

Yang

H

, .

Differentially expressed proteins underlying childhood cortical dysplasia with epilepsy identified by iTRAQ proteomic profiling

.

PLoS One

.

2017

;

12

(

2

):

e0172214

.

63.

Furukawa

A

,

Kakita

A

,

Chiba

Y

,

Kitaura

H

,

Fujii

Y

,

Fukuda

M

, .

Proteomic profile differentiating between mesial temporal lobe epilepsy with and without hippocampal sclerosis

.

Epilepsy Res

.

2020

;

168

:

106502

.

64.

Liu

XL

,

Feng

ZT

,

Du

LP

,

Huang

YG

,

Ge

JW

,

Deng

YH

, .

The potential role of MicroRNA-124 in cerebral ischemia injury

.

Int J Mol Sci

.

2019

;

21

(

1

):

120

.

65.

Yao

Y

,

Ji

YS

,

Ren

JH

,

Liu

HY

,

Khanna

R

,

Sun

L

.

Inhibition of autophagy by CRMP2-derived peptide ST2-104 (R9-CBD3) via a CaMKKβ/AMPK/mTOR pathway contributes to ischemic postconditioning-induced neuroprotection against cerebral ischemia-reperfusion injury

.

Mol Brain

.

2021

;

14

(

1

):

123

.

66.

Yu-Kemp

HC

,

Kemp

JP

Jr,

Brieher

WM

.

CRMP-1 enhances EVL-mediated actin elongation to build lamellipodia and the actin cortex

.

J Cell Biol

.

2017

;

216

(

8

):

2463

–

79

.

67.

Nagai

J

,

Baba

R

,

Ohshima

T

.

CRMPs function in neurons and glial cells: potential therapeutic targets for neurodegenerative diseases and CNS injury

.

Mol Neurobiol

.

2017

;

54

(

6

):

4243

–

56

.

68.

He

L

,

Kooistra

R

,

Das

R

,

Oudejans

E

,

van Leen

E

,

Ziegler

J

, .

Cortical anchoring of the microtubule cytoskeleton is essential for neuron polarity

.

Elife

.

2020

;

9

:

e55111

.

69.

Chen

YC

,

Huang

HR

,

Hsu

CH

,

Ou

CY

.

CRMP/UNC-33 organizes microtubule bundles for KIF5-mediated mitochondrial distribution to axon

.

PLoS Genet

.

2021

;

17

(

2

):

e1009360

.

70.

Liao

Z

,

Li

J

,

Miao

L

,

Huang

Z

,

Huang

W

,

Liu

Y

, .

Inhibition of RhoA activity does not rescue synaptic development abnormalities and long-term cognitive impairment after sevoflurane exposure

.

Neurochem Res

.

2021

;

46

(

3

):

468

–

81

.

71.

Liu

HH

,

Jan

YN

.

Mechanisms of neurite repair

.

Curr Opin Neurobiol

.

2020

;

63

:

53

–

8

.